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Abstract
Cdc7p-Dbf4p is a conserved protein kinase required for the initiation of DNA replication. The Dbf4p regulatory subunit
binds Cdc7p and is essential for Cdc7p kinase activation, however, the N-terminal third of Dbf4p is dispensable for its
essential replication activities. Here, we define a short N-terminal Dbf4p region that targets Cdc7p-Dbf4p kinase to Cdc5p,
the single Polo kinase in budding yeast that regulates mitotic progression and cytokinesis. Dbf4p mediates an interaction
with the Polo substrate-binding domain to inhibit its essential role during mitosis. Although Dbf4p does not inhibit Polo
kinase activity, it nonetheless inhibits Polo-mediated activation of the mitotic exit network (MEN), presumably by altering
Polo substrate targeting. In addition, although dbf4 mutants defective for interaction with Polo transit S-phase normally,
they aberrantly segregate chromosomes following nuclear misorientation. Therefore, Cdc7p-Dbf4p prevents inappropriate
exit from mitosis by inhibiting Polo kinase and functions in the spindle position checkpoint.
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Introduction
Accurate ordering of cell cycle events is an important
requirement for the viability of all eukaryotic organisms. Once
cells commit to duplicate their genome they must restrain mitosis
until replication is complete and then accurately coordinate
mitosis with cytokinesis to ensure the faithful transmission of
chromosomes to daughter cells [1]. Importantly, errors in cell
cycle checkpoints that enforce this ordering can be deleterious for
accurate chromosome transmission. For instance, DNA damage or
replication fork arrest during S-phase elicits a reversible block to
mitotic progression by the budding yeast Mec1p (HsATR) and
Rad53p (HsChk2) checkpoint kinases [2,3]. In the absence of
Mec1p or Rad53p, replication fork arrest during S-phase is not
sensed leading to premature mitotic events and cell death
(reviewed by [4]). Additionally, since daughter cell growth is
highly polarized in the budding yeast, exit from mitosis is
prevented until sister chromatids segregate through the bud neck
and into the daughter cell [5–7]. This ensures that spindle
disassembly and mitotic exit are not initiated until accurate
chromosome partitioning between mother and daughter cells has
occurred. Failure to block mitotic exit when nuclear division takes
place within the mother cell results in polyploid and anucleate
progeny [8,9]. It is not surprising therefore, that both entry into
and exit from mitosis are delayed by cellular checkpoints that
respond to replication stress, chromosome damage, or spindle
disruption [1]. Errors in these mitotic checkpoints are catastrophic
and result in ploidy defects and genetic alterations, which are
frequently observed in human cancers (reviewed by [10]).
The Cdc7p-Dbf4p kinase is required to catalyze the initiation of
DNA synthesis at the beginning of S-phase (reviewed by [11]).
Cdc7p kinase activity is tightly regulated during the cell cycle by
binding the Dbf4p regulatory subunit, which is cyclically expressed.
Dbf4p accumulates in late G1, is present throughout S-phase and
then is destroyed during mitosis and early G1 by anaphase
promoting complex (APC)-dependent degradation [12–17]. There-
fore, Cdc7p-Dbf4p kinase activity is low following exit from mitosis
and entry into G1-phase until it is needed to initiate a new round of
DNA synthesis in late G1-phase of the following cell cycle. Multiple
lines of evidence suggest that Cdc7p-Dbf4p activates the MCM
DNA helicase [18–20] that is assembled at origins of replication in
early G1 in an inactive form (reviewed in [21,22]).
In addition to its essential role in replication initiation, several
studies suggest that the Cdc7p-Dbf4p kinase responds to DNA
damage or replication fork stalling but its precise role in these
activities is unknown [17,23–25]. Dbf4p encodes a dispensable
BRCT-like domain in the N-terminus that might target the kinase
to stalled replication forks [26,27]. In fission yeast, the Cdc7p-
Dbf4p ortholog Hsk1p-Dfp1p interacts with Swi1p (budding yeast
Tof1p), a component of replication forks required for fork stability
and also promotes centromeric cohesion in early mitosis [28,29].
Rad53p also phosphorylates Dbf4p in response to replication stress
and this regulation requires N-terminal Dbf4p sequences through
which Rad53p physically interacts [17,25,30]. Interestingly, the
absence of the BRCT-like domain results in a defect in late origin
activation suggesting that this domain might alter Cdc7p-Dbf4p
binding at early versus late replication origins [26]. Together,
these data suggest that the Dbf4p N-terminus encodes non-
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substrates.
To identify proteins that interact with the Dbf4p N-terminus,
we performed a yeast two-hybrid screen with an N-terminal region
of Dbf4p and identified an interaction with the Cdc5p kinase, the
only Polo ortholog in yeast. Budding yeast Polo, like Drosophila
Polo and human Polo-like kinase 1 (Plk1), functions as a master
regulator of mitotic progression and is also required for cytokinesis
(reviewed by [31,32]). Polo activity is regulated by several
independent cellular mechanisms. Polo protein levels are con-
trolled by APC-dependent degradation in mitosis/G1-phase and
activation of Polo catalytic activity requires phosphorylation by
Cdk1 kinase early in G2 [33–35]. In addition, Polo function is
inhibited by cell cycle checkpoints that are induced following DNA
or spindle damage [36–38]. A genetic and physical interaction
between Dbf4 and Polo was described previously [39,40], however
the biological significance of this interaction was not known.
Polo controls multiple mitotic events to ensure accurate
chromosome segregation. After anaphase initiation, Polo is
required to activate the FEAR (Cdc14 early anaphase release)
and MEN (mitotic exit network) pathways that promote nucleolar
release of Cdc14p phosphatase [37,41–43]. Limited Cdc14p
release by the FEAR pathway promotes accurate rDNA and
telomere segregation [44–46]. Subsequent full nucleolar release of
Cdc14p by the MEN reverses Cdk substrate phosphorylation that
leads to APC-Cdh1p activation, cyclin destruction and mitotic
spindle disassembly (reviewed by [47]). Activation of the MEN is
promoted by Tem1p-GTP and antagonized by Bfa1p-Bub2p, a
two-component GTPase activating protein (GAP) [48–50]. To
promote mitotic exit, Polo phosphorylates Bfa1p-Bub2p to inhibit
its GAP activity and is also required for activation of Dbf2p kinase
activity, independently of Bfa1p-Bub2p [37,49,51,52]. The Polo
requirement for Dbf2p kinase activation may reflect that Polo also
promotes Cdc14p release in the FEAR pathway, which primes the
MEN [43]. Therefore, Polo promotes accumulation of Tem1p-
GTP and activation of the downstream MEN kinases Cdc15p and
Dbf2p, which ultimately cause full release of Cdc14p from the
nucleolus. In response to replication fork arrest, Rad53 inhibits
MEN activation, which may or may not impact Polo activity since
the molecular basis of this regulation is not understood [53,54].
Spindle position defects also counteract Polo activity by targeting
Kin4p kinase to the spindle poles where it inhibits Polo-dependent
Bfa1p phosphorylation [8,9,55]. Failure to execute the spindle
position checkpoint (SPOC) results in premature exit from mitosis
and nuclear partitioning defects.
Here we define an N-terminal Dbf4p polo-box interaction
region (that we refer to as the ‘‘PIR’’) that binds directly to Polo
and show that Dbf4p inhibits Polo and Dbf2p activity. Deletion of
the PIR allows Cdc14p nucleolar release in a cdc5-1 mutant at the
non-permissive temperature. In response to nuclear misposition-
ing, a dbf4 mutant lacking the PIR fails to arrest in mitosis and
prematurely exits the cell cycle. Thus, Dbf4 protein is required for
proper functioning of the spindle position checkpoint most likely
by antagonizing the ability of Polo to promote Cdc14p release in
either the FEAR or MEN pathways. Our work therefore reveals a
previously unrecognized function for Dbf4p in the regulation of
mitotic progression through a direct interaction with Polo.
Results
The Cdc5p Polo-Box Domain Interacts with the Dbf4p N-
Terminus
We conducted a yeast two-hybrid screen to identify proteins
that interact with the Dbf4p N-terminus (residues 67–227) and
recovered multiple clones encoding the polo-box domain (PBD) of
Cdc5p. Polo kinase has two conserved domains; an N-terminal
kinase domain and a C-terminal region called the polo-box
domain (PBD) (reviewed by [56]), which is a phospho-Ser/Thr
binding module that targets the kinase to its mitotic substrates
[57,58]. The crystallographic structure of the Plk1 PBD bound to
a phospho-threonine peptide has been solved [59]. Since the
Dbf4p BRCT-like region alone (residues 110–227) failed to
interact with the Polo PBD (Figure 1A), this suggested that the
PBD interaction was occurring through Dbf4p N-terminal
sequences from 67–109. Residues 67–109 were similarly required
for the Polo interaction within the context of full length Dbf4p
(Figure 1B) and were sufficient to interact with the Polo PBD
(Figure 1A). Dbf4p residues 67–109 with all serines/threonines
changed to alanine still interacted with the PBD (Figure 1A)
suggesting that the PBD can bind to this Dbf4p region
independently of phosphorylation. Further deletion and point
mutant analysis (Y-C.C. and M.W., unpublished data) revealed
that residues 82–88 are essential for the Dbf4p-Polo interaction
(Figure 1A, B).
The PBD is composed of three conserved regions called the
Polo-cap (Pc), Polo-box 1 (PB1) and Polo-box 2 (PB2) that fold
together to form a functional phosphopeptide-binding domain
[59]. We deleted conserved residues within the PBD to test their
requirement for interaction with Dbf4p (Figure 1C). Deletion of
residues preceding the PBD (GAD-Polo454–705) had little effect on
the Dbf4p-Polo interaction. However, elimination of the Pc (GAD-
Polo510–705) completely disrupted the interaction with Dbf4p.
These data suggest that the structural integrity of the Polo PBD is
required for Dbf4p binding.
Dbf4p Directly Interacts with Polo
Dbf4p binds and activates the Cdc7p kinase subunit in yeast
and has no known role apart from its interaction with Cdc7p
[14,60]. To determine whether the interaction between Dbf4p and
Polo occurred in the context of the full-length Cdc7p-Dbf4p
kinase, Sf9 cells were co-infected with baculoviruses expressing
Polo, wild type HA-Cdc7p-Dbf4p or wild type HA-Cdc7p with
various Dbf4p deletion derivatives. HA-Cdc7p-Dbf4p kinase was
immunoprecipitated using an antibody against the HA tag and
examined for the presence of Polo. All the Dbf4p deletion
Author Summary
Cdc7p-Dbf4p is a two-subunit enzyme required to copy
the genetic material present on every chromosome in a
process termed DNA replication. Dbf4p is an essential
regulatory subunit of this enzyme that likely directs the
Cdc7p subunit to its targets within the cell. We found that
Dbf4p physically interacts with another protein called Polo
that acts during mitosis, a later step in the cell cycle when
the newly copied chromosomes are equally divided to
mother and daughter cells. Polo is a master regulator of
mitosis and impacts many other proteins required for cell
division. We determined that Cdc7p-Dbf4p is a Polo
inhibitor and, further, that Cdc7p-Dbf4p delayed or
prevented chromosome segregation when errors occurred
during the cell division process. Interestingly, Dbf4p may
bind the Polo substrate-binding domain using a type of
interaction not previously described. Thus, we have
uncovered a new activity for Cdc7p-Dbf4p in the cell
cycle to inhibit chromosome segregation, and these
findings impact multiple fields that investigate how cells
accurately copy and segregate their chromosomes.
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Cdc7p kinase activity ([26] and data not shown). Whereas Polo
interacted with full-length Cdc7p-Dbf4p and Cdc7p-Dbf4-ND65p,
Polo did not interact with Cdc7p-Dbf4p complexes that lacked the
Dbf4p N-terminal 109 residues required for the Polo two-hybrid
interaction (Figure 2A). These data indicate that full length Cdc7p-
Dbf4p kinase interacts with Polo but that Dbf4p residues 65–109
are required for this interaction. Importantly, HA-Cdc7p-Dbf4p
interacts with Cdc5p in yeast when the proteins are expressed at
endogenous levels and this interaction also depends on the Dbf4p
N-terminus (Figure 2B).
We next tested whether Polo bound directly to Dbf4p using
purified proteins. GST-PBD and Sumo-Dbf4p67–109 fusion
proteins purified from E. coli were mixed, pulled down using
glutathione-Sepharose and analyzed by immunoblotting. Al-
though Sumo alone did not interact with GST-PBD, Sumo-
Dbf4p67–109 interacted with GST-PBD but not with GST alone
(Figure 2C). These data indicate that Dbf4p residues 67–109 (that
we refer to as the Dbf4p PIR) are sufficient for a direct interaction
with the Polo PBD.
Dbf4p Inhibits Polo Activity
Cdc7p-Dbf4p is required to initiate DNA replication, but is
present throughout S-phase and during the metaphase to
anaphase transition. Dbf4p is subject to APC-Cdc20p dependent
degradation [16] but some protein is still present in late mitotic
mutants that have activated the Cdc20p but not the Cdh1p form
of the APC [17]. We examined Dbf4 protein abundance relative
to Pds1 protein in cells moving synchronously through the cell
cycle, since Pds1p is degraded at the onset of anaphase by APC-
Cdc20 [61]. We found that although the abundance of both
proteins declines at the same time, Pds1p is absent during mitosis
while some fraction of Dbf4p persists (Figure S5). In contrast,
Dbf4p has very low abundance or is absent in cells arrested in G1-
phase by mating-pheromone when the APC-Cdh1p is active
[12,13,15,17] and Dbf4p is stabilized by inactivation of the APC in
Figure 1. The N-terminus of Dbf4p interacts with the Polo PBD. Cells co-transformed with various bait GAL4 DNA binding domain fusions
(GBD-DBF4) and prey GAL4 activation domain fusions (GAD-CDC5) constructs were spotted at 10-fold serial dilutions on SCM–Trp –Leu and SCM–Trp–
Leu–His plates containing 2 mM 3AT (A, C) or 0.5 mM 3AT (B) and incubated at 30uC for 2 to 3 days. The GBD-Dbf4 protein levels are shown in Figure
S1.
doi:10.1371/journal.pgen.1000498.g001
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these data suggest that Dbf4p degradation can occur via both
APC-Cdc20p and APC-Cdh1p mediated ubiquitylation.
Since budding yeast Polo is not required for DNA replication
but promotes multiple mitotic activities, we reasoned that Cdc7p-
Dbf4p might influence Polo activity during mitosis. The dbf4-
ND109 mutant progresses normally through the cell cycle and does
not exhibit any obvious growth defects or temperature sensitivity
(Figure 3A, B) [26]. We therefore tested for genetic interactions
between dbf4-ND109 and the cdc5-1 temperature sensitive (ts)
mutant. At the restrictive temperature cdc5-1 cells arrest in late
telophase with divided nuclei, elongated spindles and high Cdk1p-
Clb2p levels indicating a failure to exit mitosis [34,35,62]. The
cdc5-1 mutant is ts at 30uC on rich media, but we found that dbf4-
ND109 suppressed the cdc5-1 temperature sensitivity up to 35uC
indicating a strong suppression of its growth defect (Figure 3A).
The dbf4-D82–88 mutant defective for interaction with Polo also
suppressed the cdc5-1 ts (Figure 3A). Since the cdc5-1 ts suppression
was reduced in heterozygous dbf4-ND109/DBF4 diploids com-
pared to dbf4-ND109/dbf4-ND109 diploids, i.e. dbf4-ND109 was
haploinsufficient (Figure 3C), our data strongly suggests that
Dbf4p is a Polo inhibitor and that loss of the Dbf4-Polo interaction
leads to increased cdc5-1 activity.
We confirmed that Dbf4p inhibited Polo activity using several
independent genetic tests. An extra plasmid copy of wild type
DBF4 but not dbf4-ND109 inhibited the growth of cdc5-1 cells
(Figure 3D). A dbf4-ND65 mutant that disrupts the D-box (residues
62–70) resulting in elevated protein levels was synthetically sick or
lethal in combination with cdc5-1 (Figure 3E). Since the dbf4-ND65
mutant exhibits a wild type growth rate and normal S-phase entry
and progression (data not shown; [26]) but binds to Polo, this
suggests that elevated Dbf4p levels are deleterious to cdc5-1
activity. Finally, elevated expression of the Dbf4p N-terminus from
the GAL1 promoter completely inhibited the growth of cdc5-1 cells
but had no effect on the growth of wild type (not shown) or a
mcm2-1 ts mutant. Mcm2 is a component of the MCM helicase,
which is thought to be the physiological target of Cdc7p-Dbf4p
during the initiation of DNA replication [11]. The inhibition of
cdc5-1 growth depended on the Dbf4p-Polo interaction, since
deletion of the PIR (residues 66–109) or Dbf4p residues 82–88
abrogated the growth inhibition (Figure 4A, B). Since the Dbf4p
N-terminus interacts with the PBD, this data suggest that
Figure 2. Dbf4p residues 67–109 interact directly with the Polo PBD. (A) HA-Cdc7p-Dbf4p kinase or HA-Cdc7p plus Dbf4p truncation
mutants were expressed in Sf9 cells together with Polo and immunoprecipitated using 12CA5 antibody. Blots were probed with anti-Myc (Cdc5p),
anti-Cdc7p and anti-Dbf4p polyclonal antibodies. (B) Endogenous HA3-Cdc7p-Dbf4p complexes were immunoprecipitated using 12CA5 antibody
from HA3-CDC7 DBF4 CDC5-Myc15 (M2741) and HA3-CDC7 dbf4-ND109 CDC5-Myc15 (M2743) yeast strains following nocodazole arrest and probed for
Cdc7, Dbf4, and Cdc5-Myc. (C) Purified Sumo and Sumo-Dbf467–109 proteins were co-incubated with purified GST-PBD or GST alone; proteins were
pulled down using glutathione-Sepharose beads and blotted with antibodies against GST or Sumo. (D) In vitro phosphorylation of GST-PBD using
purified Cdc7p-Dbf4p kinase.
doi:10.1371/journal.pgen.1000498.g002
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essential Polo-substrate interactions by competitive inhibition.
Together, these data indicate that the Dbf4p N-terminus inhibits
Polo activity and that this inhibition requires residues 66–109,
which are also required for the Dbf4p-Polo physical interaction.
We wanted to determine whether the Cdc7p kinase subunit is
required to inhibit Polo in the FEAR or MEN pathways. This is
not straightforward since Cdc7p is an essential protein kinase.
Importantly, inhibiting Cdc7p activity would not only inhibit
replication origin firing but would also likely induce the replication
checkpoint that inhibits the metaphase to anaphase transition and
MEN activation [4]. Inhibiting Cdc7p activity would thus interfere
with the mitotic pathways we would like to measure. Therefore,
we addressed this question indirectly by taking advantage of our
observation that high copy dbf4-ND109 suppressed the cdc5-1 ts
phenotype (Figure 4C). Since Dbf4p residues required for
interaction with Cdc7p map between residues 312–704 (C.G.
and M.W. unpublished data), Dbf4-ND109 protein (expressed in
high copy) will compete with full length Dbf4p (in single copy) for
Cdc7p binding. Therefore, our finding suggested that high copy
expression of Dbf4-ND109p reduced the cellular concentration of
wild type Cdc7p-Dbf4p, the likely Cdc5p inhibitor, which
suppressed the cdc5-1 ts allele (Fig 4C). High copy expression of
Dbf4-D82–88p that does not interact with Polo also suppressed the
cdc5-1 ts (Fig 4C). Importantly, deleting Dbf4p C-terminal residues
required for interaction with Cdc7p (CD312–704) eliminated the
ts suppression by high copy dbf4-ND109 and dbf4-D82–88. These
data are consistent with full-length Cdc7p-Dbf4p kinase acting as
the physiological Polo inhibitor.
Cdc7p-Dbf4p Phosphorylates the PBD
Wild type Cdc7p-Dbf4p might inhibit Polo abundance or kinase
activity during the cell cycle and thus explain our genetic data.
However, we saw little difference in Polo protein levels, cell cycle
expression or Polo kinase activity comparing wild type yeast with
the dbf4-ND109 mutant (Figure S2). This suggests that Dbf4p
inhibits Polo independently of altering its expression or kinase
activity. This is consistent with our genetic data since loss the
Dbf4p PIR suppresses the cdc5-1 allele yet the Cdc5-1 protein
retains considerable protein abundance and kinase activity at the
non-permissive temperature [63]. The mitotic exit defect associ-
ated with cdc5-1 is due to a single P511L amino acid substitution
preceding polo-box 1 of the PBD [64], strongly suggesting that the
cdc5-1 growth defect is caused by a defect in substrate recognition.
Since genetically DBF4 is a negative CDC5 regulator we
hypothesized that Cdc7p-Dbf4p phosphorylates Polo to prevent
Figure 3. The Dbf4p N-terminus inhibits Polo activity. (A) dbf4-ND109 rescues the cdc5-1 temperature sensitivity. Indicated strains were
spotted at ten-fold serial dilution on YPD and grown at increasing temperatures. (B) Cell cycle progression of wild type and dbf4-ND109 at 30uCb y
flow cytometry of alpha-factor arrested (t=0) and released cells (t=10 to 180 mins). (C) The indicated diploid strains were spotted at increasing
temperatures (D) DBF4 cdc5-1 was transformed with the indicated ARS CEN plasmids and spotted at 25uC and 32uC (E) Representative tetrads from a
dbf4-ND65 (M2007) cross to cdc5-1 (M1614).
doi:10.1371/journal.pgen.1000498.g003
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possibility, we found that purified Cdc7p-Dbf4p phosphorylated
recombinant GST-PBD but not GST alone (Figure 2D).
Dbf4p Inhibits Cdc14p Nucleolar Release
The Cdc14p phosphatase is sequestered within the nucleolus
during the cell cycle prior to FEAR and MEN pathway activation
[50,65]. Activation of the FEAR pathway allows limited Cdc14p
nucleolar release, which promotes rDNA and telomere segregation
during early anaphase [42,44–46]. Cdc14p is then fully released
by MEN activation and antagonizes Cdk activity to trigger exit
from mitosis [66]. Since the cdc5-1 mutant fails to release Cdc14p
at the restrictive temperature [66], suppression of the cdc5-1 ts by
deletion of the Dbf4p PIR (Figure 3A) suggested that Cdc14p
release is likely restored in these cells at higher temperatures. We
quantitated the nucleolar release of Cdc14-EGFP in wild type,
dbf4-ND109, cdc5-1 and cdc5-1 dbf4-ND109 cells at a restrictive
temperature for cdc5-1. Cells were arrested in G1-phase at the
permissive temperature and then released into the cell cycle at
34uC. The dbf4-ND109 cells progressed through the cell cycle and
released Cdc14p similarly to wild type cells (Figure 5A). Consistent
with previous reports, the cdc5-1 mutant failed to release Cdc14p
from the nucleolus but a significant amount of Cdc14p was
released from the nucleolus in the cdc5-1 dbf4-ND109 mutant
(Figure 5A). We noticed a delay in mitotic progression at 34uCi n
the cdc5-1 dbf4-ND109 cells evidenced by a somewhat longer
duration of Cdc14p release compared to the wild type and delayed
cytokinesis (indicated by the delayed appearance of unbudded (G1)
cells). This data indicates that Dbf4p inhibits Polo activity to
prevent Cdc14p release, which might be significant during a
slowed S-phase or during periods of replication stress.
Dbf4p Also Inhibits the MEN Kinase Dbf2p
Inactivation of Bfa1p-Bub2p is required to activate the MEN
[37]. This signaling cascade is partially activated as a result of
Bfa1p phosphorylation by Polo, which leads to activation of the
Cdc15p and Dbf2p-Mob1p kinases (reviewed by [47]). Dbf2p
kinase activation requires a Bub2p-Bfa1p independent function of
Polo as well [49], indicating that Polo either directly promotes
Dbf2p kinase activity or promotes a MEN-independent pathway
that activates Dbf2p. We tested whether Dbf4p functions as a
negative regulator of MEN activation by examining whether
deletion of the Dbf4p PIR could suppress growth defects
associated with additional ts mutants in the MEN (Figure 5B).
We examined the growth of double mutants of cdc5-1, cdc15-2,
dbf2-1, cdc14-1,o rcdc14-3 with dbf4-D109. As with cdc5-1, loss of
the DBF4 PIR rescued the growth of dbf2-1 cells at the non-
permissive temperature. In contrast, the dbf4-D109 mutant failed
to suppress the ts phenotype of cdc15-2, cdc15-4 (not shown), cdc14-
1,o rcdc14-3 mutants (Figure 5B). This suggests that Dbf4p may
specifically inhibit Polo activation of Dbf2p and not Polo
inactivation of Bub2p-Bfa1p GAP activity. Taken together, our
observations suggest that Dbf4p antagonizes Polo activation of
some Bfa1p-Bub2p independent step in MEN activation. This
interpretation is further supported by the following experiments.
Dbf4p Regulates a Bfa1p-Bub2p Independent Polo
Activity during Mitotic Exit
Deletion of BUB2 (or BFA1) is sufficient to cause premature
mitotic exit when cells are arrested in metaphase with the spindle
poison nocodazole [67,68]. This causes large budded cells to exit
mitosis and rebud in the absence of chromosome segregation or
cytokinesis. Since Dbf4p is a negative regulator of Polo activity, we
Figure 4. Dbf4p is a Polo inhibitor. (A) cdc5-1 and mcm2-1 strains expressing the indicated Dbf4 N-terminal regions from the GAL1 promoter
were plated onto glucose (repressing conditions) or galactose to induce Dbf4p expression. (B) Dbf4p Western blot of total cell extracts induced for
GAL1-DBF4 expression at 0, 3, and 6 hours. Asterisks indicate N-terminal Dbf4 peptides. (C) High copy vectors expressing wild type DBF4 and mutant
genes were transformed into cdc5-1 (M1614) and spotted at 10-fold serial dilutions at the indicated temperatures.
doi:10.1371/journal.pgen.1000498.g004
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induce rebudding in the presence of spindle poisons. Cells were
arrested in G1, released into media containing nocodazole and
quantitated for rebudding (Figure 6A). In contrast to bub2D, dbf4-
ND109 did not allow rebudding in a wild type background nor did
this mutation advance rebudding in a bub2D background. This
indicated that loss of the Dbf4p Polo interaction is not sufficient to
cause mitotic exit during metaphase and suggested that Dbf4p
Polo inhibition may act independently of Bub2p-Bfa1p.
Null alleles of CDC5 fail to activate the MEN and arrest in
telophase with unphosphorylated Bfa1 [37]. Although the cdc5-1
mutant is also defective in MEN activation it is proficient for Bfa1p
phosphorylation and retains substantial Polo kinase activity at the
non-permissive temperature (NPT) [37,63]. This suggests that the
cdc5-1 mutant is defective in activating a Bfa1p-independent
function of the MEN, perhaps in FEAR pathway activation or
activating a downstream MEN target. In contrast to cdc5-1, cdc5-2
cells neither phosphorylate Bfa1p nor activate the MEN at the
NPT [37]. The cdc5-2 temperature sensitivity is partially rescued
by deletion of either BFA1 or BUB2 [37] but not by dbf4-ND109
(Figure 6B). However, in a bub2D the cdc5-2 temperature sensitivity
was further suppressed by deletion of the Dbf4p PIR. So,
eliminating the requirement for Bfa1p-Bub2p inactivation in
cdc5-2 cells (i.e. cdc5-2 bub2D), allowed dbf4-ND109 to further
suppress the cdc5-2 ts and promote mitotic exit at 34uC (Figure 6B).
These data are consistent with the interpretation that Dbf4p
primarily inhibits Polo activation of a Bub2p-Bfa1p independent step
in MEN activation, e.g. Dbf2p activity, Cdc14p release in the
FEAR pathway, or some unknown activity.
DBF4 Prevents Mitotic Exit When the Nucleus Is
Mispositioned
In the budding yeast, KAR9 and DYN1 encode cytoplasmic
microtubule-associated and motor proteins, respectively, that
operate in two redundant pathways essential for the correct
positioning of the nucleus during anaphase (reviewed by [7]).
Deletion of either gene results in a small percentage of cells with
nuclear orientation defects but deletion of both genes is lethal. In
response to nuclear misorientation, S. cerevisiae inhibits premature
activation of the MEN via the spindle position checkpoint (SPOC).
Figure 5. DBF4 inhibits Cdc14p nucleolar release and the MEN pathway. (A) Deletion of the Dbf4p PIR rescues Cdc14p nucleolar release at
high temperature. M1992, M2005, M2139 and M2287 were arrested with alpha-factor at 25uC and released into YPD at 34uC followed by alpha-factor
re-addition at 60 minutes. Entry and exit from the cell cycle was analyzed as a percentage of budded cells. Cdc14-EGFP release was analyzed in at
least 100 cells at each time point and is reported as a percentage of cells with diffuse Cdc14p-EGFP nuclear staining (absence of nucleolar Cdc14p). (B)
dbf4-ND109 rescues the growth defect of the cdc5-1 and dbf2-1 strains at 35uC. Single and double mutant strains were spotted at 10-fold dilutions on
YPD and incubated at increasing temperatures for 2 to 3 days.
doi:10.1371/journal.pgen.1000498.g005
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pole bodies (SPB) to counteract Polo Bfa1p phosphorylation
[8,9,55]. Kin4p thus counteracts Polo inactivation of the Bfap1-
Bub2p GAP and this inhibits MEN activation. Failure to
adequately respond to nuclear mispositioning allows inappropriate
nuclear division within the mother cell, leading to anueploidy and
loss of viability. Given that Polo Bfa1p phosphorylation is
prevented when the SPOC is activated, we hypothesized Dbf4p
may also inhibit Polo to prevent mitotic exit in response to nuclear
misorientation.
To test whether DBF4 inhibited mitotic exit when nuclei were
mispositioned, we examined wild type, dbf4-ND109, kar9D and
kar9D dbf4-ND109 strains for evidence of mitotic exit in the
presence of mispositioned nuclei. Asynchronous cultures were
grown at 25uC and shifted to 30uC for 4 or 24 hours prior to
analysis to increase the penetrance of the nuclear mispositioning
phenotype. Although wild type and dbf4 mutant cells did not
misorient their nuclei (Figure 7C), both kar9D and kar9D dbf4-
ND109 strains had approximately equal number of cells with
nuclear positioning defects. Importantly, deletion of the Dbf4p
PIR resulted in a 2 to 3-fold increase (to 6%) in binucleate,
anucleate and multinucleate cells at 4 hours (Figure 7A, C, D),
which was CDC5-dependent, suggesting that premature mitotic
exit occurred. At 24 hours the number of aberrant chromosome
segregation events due to loss of the Dbf4p PIR increased six-fold
(12%) relative to kar9D alone (2%). Since exit from mitosis causes
spindle disassembly, we quantitated the spindle morphology in
cells containing correctly segregated nuclei (between the mother
and daughter cells) and in those cells where anaphase had initiated
solely within the mother cell. Although kar9D and kar9D dbf4–
ND109 cells had similar frequencies of intact or disassembled
spindles when nuclear division proceeded normally, kar9D dbf4-
ND109 cells showed a three-fold increase in spindle disassembly
within the mother cell (leading to a bi-nucleate mother cell)
compared to kar9D single mutants at 4 hours (Figure 7D). These
data indicate that mitotic exit occurs in these cells in the absence of
the Dbf4p PIR.
Similarly, we tested whether deletion of the Dbf4p PIR allowed
premature mitotic exit in cells disrupted in the dynein pathway
(Figure 7B, E, F). The spindle-positioning defect associated with
deletion of DYN1 is especially prominent at low temperatures.
Although after 8 hours at 14uC only ,3% of dyn1D cells had
exited mitosis inappropriately, deletion of the Dbf4p PIR resulted
in a 3- to 4-fold increase in mitotic exit as evidence by the
appearance of multinucleate and anucleate cells (Figure 7E) and
this frequency was increased at 24 hours. For comparison, a dyn1D
bub2D strain had a similar but higher frequency of segregation
defects (Figure 7E, F). Therefore, the bypass of the SPOC
following loss of the Dbf4p-Polo interaction is comparable to
deletion of the MEN inhibitor BUB2. As with the kar9D mutant,
we observed that a higher percentage of dyn1D dbf4-ND109 cells
compared to dyn1D single mutants that divided nuclei within the
mother cell had disassembled their spindles (Figure 7F). These
observations indicate that deletion of the Dbf4p N-terminus
(including the PIR) overrides the mitotic arrest normally activated
by the SPOC.
Figure 6. DBF4 regulates mitotic exit independently of BFA1-BUB2. (A) Deletion of the DBF4 polo-box interacting region does not cause
rebudding. W303-1A, M1652, M1656 and M1860 were synchronized with alpha-factor and released into YPD containing 15 ug/ml of nocodazole at
30uC. Samples were quantitated for the percentage of rebudded cells (large budded cells with a new bud). (B) Deletion of BUB2 and the DBF4 PIR
cooperate to suppress the growth defect of cdc5-2. Strains of the indicated genotypes were spotted at 5-fold serial dilutions on YPD and grown at
increasing temperature. Two isolates are shown for the cdc5-2 recombinants.
doi:10.1371/journal.pgen.1000498.g006
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We found that Dbf4p inhibited Polo kinase during mitosis very
likely through a direct interaction with the polo-box domain. This
interaction inhibited MEN pathway activation, nucleolar release
of the Cdc14p phosphatase and was likely critical to maintain
genome integrity during activation of the spindle position
checkpoint. These results therefore have important implications
for understanding Dbf4p function and the regulation of mitotic
progression in eukaryotic cells.
Defining the Interaction between Dbf4p and Polo
The N-terminal third of Dbf4p encodes multiple functions: a
destruction box (residues 62–70), two putative nuclear localization
signals (residues 55–61, 251–257) and a BRCT-like domain
(residues ,117–220). Nonetheless the 265 N-terminal amino acids
of Dbf4p are not essential as long as a nuclear localization signal is
present [26]. Deletion of the Dbf4p N-terminus through the PIR
has no observable effect on growth, viability, or cell cycle
progression either under normal growth conditions or in the
presence of replication or spindle poisons ([26] and data not
shown). Here, we discovered an interaction between Dbf4p and
the Polo PBD that mapped to a short sequence of ,40 amino
acids preceding the BRCT-like domain. Although a two-hybrid
interaction between Polo and Dbf4p was reported before [39], the
significance of this interaction was not determined.
The Polo PBD functions as a module for binding phosphory-
lated proteins and thereby targets Polo to its cellular substrates
[57,59]. The question naturally arises as to whether phosphory-
lation of the Dbf4p PIR is required for PBD binding. Currently,
our observations suggest that phosphorylation is not required. A
polo-box binding consensus sequence (S(pS/pT)P/X) is not
present within this region of Dbf4p [59] and mutation of all
putative serine and threonine residues within the Dbf4p PIR did
Figure 7. Deletion of the DBF4 PIR allows exit from mitosis in cells with misoriented nuclei. (A, B) Representative cells showing nuclear
positioning and mitotic arrest defects. Nuclear position was analyzed after DAPI staining. Cells with anaphase spindles located exclusively in the
mother cell body are noted (white arrow). Anucleate (*), binucleate (**) and multinucleate (***) cells were frequently observed in kar9D dbf4-ND109
(A) and dyn1D dbf4-ND109 (B) cells. (C, E) Quantitation of nuclear segregation defects. .300 cells were counted for each strain and nuclear position
was represented as a percentage of the total cells in culture. Black bars represent cells with nuclei segregated between mother and daughter cells;
gray bars, divided nuclei in the mother cell; white bars, multinucleate and anucleate cells. (D, F) Spindle morphology of strains with misoriented
nuclei and spindles. .50 cells were counted for each genotype. Black bars represent cells with mitotic spindles. Gray bars represent cells that have
exited mitosis.
doi:10.1371/journal.pgen.1000498.g007
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These data suggest that phosphorylation of Dbf4p is not crucial for
Polo binding. Our observation that the Dbf4p PIR purified from
E. coli directly interacted with the Polo PBD also supports this
notion. Thus phosphorylation of Dbf4p was not critical for binding
to Polo in vitro, but we cannot exclude the possibility that
phosphorylation contributes to Dbf4p-Polo binding in vivo when
the two proteins are present at physiological concentrations.
When Does Dbf4p Inhibit Polo and Mitotic Exit?
The finding that deletion of the Dbf4p PIR significantly
suppressed the ts phenotype of cdc5-1 suggests that Cdc7p-Dbf4p
inhibits Polo during the normal cell cycle and perhaps during
periods of replication stress, when Cdc7p-Dbf4p is stabilized [17].
Our data clearly demonstrate a role for Dbf4p in inhibiting mitotic
exit, since loss of the Dbf4p PIR suppressed both cdc5 and dbf2 ts
mutants and allowed sustained Cdc14p phosphatase release and
cytokinesis in the cdc5-1 mutant at the NPT. However, during an
unperturbed cell cycle the absence of this regulation had little
impact. This is likely attributable to the fact that the cell cycle
regulation of Polo activity is complex and modulated by multiple
cell cycle checkpoints. Since dbf4-ND109 bub2D double mutants
were more sensitive to growth on spindle poisons than either
mutant alone (Figure S3), the Dbf4p-Polo and Bfa1p-Bub2p
pathways may work together to suppress premature activation of
the mitotic exit network.
It was shown very recently that increased expression of a non-
destructible form of Dbf4p (Dbf4-ND65p) could delay rDNA
segregation when Clb5p was also stabilized [16]. This raises the
possibility that Dbf4p inhibits Cdc14p release via the FEAR
pathway under some circumstances and is consistent with our data
showing that Dbf4p is a Polo inhibitor. However, we found no
evidence that the dbf4-ND109 allele promoted premature rDNA
segregation (a FEAR pathway event) in the cdc5-1 mutant (Figure
S4). Similarly, we found no evidence that dbf4-ND109 caused
premature Cdc14p release in a strain deleted for FOB1, which is
thought help sequester Cdc14p in the nucleolus (Figure S4). These
data suggest that Dbf4p is not specifically inhibiting the FEAR
pathway.
The budding yeast SPOC prevents premature exit from mitosis
in part by inducing Kin4p phosphorylation of Bfa1p, which
antagonizes the Polo-dependent inhibition of the Bfa1p-Bub2p
GAP [8,9,55]. Premature exit from mitosis in dbf4-ND109 dyn1
and dbf4-ND109 kar9 double mutants suggests that Dbf4p
regulation of Polo is critical for robust cell cycle control in
response to nuclear mispositioning. What remains unclear
however, is whether this Dbf4p activity is regulated following
activation of the SPOC. For instance, Cdc7p-Dbf4p may inhibit
Polo to buffer against premature release of Cdc14p during late S-
phase or early M-phase whether or not the SPOC is activated.
Therefore, in the absence of the Dbf4p-Polo regulation Polo may
prematurely activate the MEN before a nuclear orientation defect
is sensed by the SPOC. Following APC-Cdc20p and APC-Cdh1p
activation during anaphase onset and exit, we suggest that
degradation of Dbf4p provides a positive feedback loop for full
Polo activation of the MEN and ultimately, cytokinesis.
How Does Dbf4p Inhibit Polo and Mitotic Exit?
Dbf4p did not influence Polo protein levels or overall kinase
activity. Dbf4p nonetheless inhibited Polo activity since dbf4
mutants unable to interact with Polo significantly suppressed the
cdc5-1 temperature sensitivity. Since the cdc5-1 allele retains
significant Polo protein expression, Bfa1p phosphorylation and
overall Polo kinase activity at the non-permissive temperature
[37,63], the primary cdc5-1 MEN defect is in a Bfa1p-independent
requirement for MEN pathway activation, perhaps Dbf2p
activation or some other MEN-dependent step. Our observation
that the dbf2-1 temperature sensitivity was also suppressed by loss
of the Dbf4p PIR suggests that Dbf4p may specifically inhibit Polo
activation of Dbf2p kinase independently of Bfa1p-Bub2p
phosphorylation. Dbf2p was recently shown to promote cytoplas-
mic Cdc14p localization following MEN activation [69]. In
addition, deletion of both BUB2 and the DBF4 PIR suppressed
the cdc5-2 ts better than either single mutant alone. In other words,
since dbf4-ND109 further suppressed the ts phenotype of a cdc5-2
bub2D strain, this supports the contention that Dbf4p regulates
MEN activity independently of Bfa1p-Bub2p. Deletion of the
Dbf4p PIR also did not allow rebudding in the presence of spindle
poisons as seen in bub2D mutants, again suggesting that Dbf4p
plays a minor or redundant role to inhibit Polo phosphorylation of
Bfa1p-Bub2p.
Cdc7p-Dbf4p kinase phosphorylated the Polo PBD in vitro
suggesting that Cdc7p-Dbf4p may antagonize Polo substrate
binding. This possibility is consistent with the requirement for the
PBD for targeting Polo to sites of MEN activity. Polo, Cdc15p,
Dbf2p and Bfa1p-Bub2p are localized to SPB prior to activation of
the mitotic exit network [47]. Thus, we favor a model whereby
Cdc7p-Dbf4p kinase inhibits precocious Polo binding to critical
MEN substrate(s) by phosphorylating the Polo PBD. It will be
interesting to investigate whether the Cdc7p-Dbf4p inhibition of
Polo is regulated by cell cycle checkpoints and to determine the
precise activity of Polo that is affected.
Materials and Methods
Construction of Yeast Strains, Plasmids, and
Baculoviruses
Strains and plasmids used in this study are listed in Tables S1
and S2, and supplemental methods in the Text S1 file. PJ69-4a
cells (MATa trp1-901 leu2-3,-112 ura3-52 his3-200 gal4D gal80D
LYS2::GAL1-HIS3 GAL2-ADE2 met::GAL7-lacZ) were used for two-
hybrid experiments. All other strains were derivatives of W303
(MATa ade2-1 trp1-1 can1-100 leu2-3, -112 his3-11, -15 ura3-1).
Construction of Dbf4p N-terminal truncation mutants was
previously described [26]. Cdc14-EGFP was constructed as
described [70]. bub2D strains were created by replacement of the
BUB2 ORF via homologous recombination with SacI-ClaI
bub2D::URA3 fragment from pTR24 (A. Hoyt). The BAR1 ORF
was deleted by homologous recombination with linearized pZV77
containing bar1::LEU2 (B. Futcher). Construction of KAR9 and
DYN1 deletions were previously described [8].
For yeast two-hybrid analyses, a Gal4 DNA binding domain
(GBD) fusion to Dbf4p67–227 was constructed by PCR amplifica-
tion of Dbf4p residues 67–227 (NcoI-PstI) and cloned into
pGBKT7 (Clonetech). Deletion of 71 bp within the ADH1
promoter sequence of pGBKT7 (-647 to -717 from the ATG)
removed a Rap1p binding site and reduced the strength of GBD-
Dbf4p67–227 expression (which was otherwise lethal) to give
pCG60. Point mutations and deletions were generated by site-
directed mutagenesis using the QuikChange system (Stratagene).
For all mutations, the entire coding sequence was verified by DNA
sequencing. Construction of baculovirus plasmids encoding WT,
ND65Dbf4p, ND109Dbf4p, ND221Dbf4p and HA-Cdc7p was
previously described [26]. The baculovirus transfer plasmid
containing 3Myc-ND65Polo was constructed in pAcSG2 (BD
Biosciences). High-titer baculoviruses were generated by transfec-
tion of Sf9 cells using the BaculoGold kit (BD Biosciences) followed
by plaque purification and virus amplification.
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357–705 were PCR amplified with BamHI-XmaI linkers and
cloned into pGEX-KG for expression of GST-PoloPBD in E. coli.
The region encoding Dbf4p amino acids 66–109 was PCR
amplified from pMW489 with BsaI-BamHI linkers and cloned into
pSUMO (LifeSensors Inc.) for expression of Sumo-Dbf4p67–109.
Growth Media and Cell Cycle Experiments
Cells were cultured in YPD (1% yeast extract, 2% bacto
peptone, 2% glucose). Synchronous G1 cultures were obtained
after addition of 5 mg/ml (0.1 mg/ml in bar1D cells) alpha-factor to
cells for 3 hours. DNA content was analyzed by flow cytometry as
previously described [17]. Drugs were added directly to plates
immediately before pouring.
Two-Hybrid Experiments
PJ69-4a cells containing pCG60 were transformed with a S.
cerevisiae two-hybrid library. Interacting clones were recovered on
medium lacking tryptophan, leucine, and histidine but containing
2 mM 3-aminotriazole at 30uC. Positive interactors were streak-
purified and also tested for ADE2 reporter activity. Prey plasmids
that activated both HIS3 and ADE2 expression were confirmed by
retransformation in PJ69-4a and then sequenced. To quantify two-
hybrid interactions, co-transformed cells were spotted at ten-fold
serial dilutions on selective media and grown for 2–3 days.
Yeast Whole-Cell Extract Preparation,
Immunoprecipitation, and Blotting
Yeast protein extracts were prepared for Western blotting by
trichloroacetic acid extraction [71] or for immunoprecipitation
(IP) by bead-beating in NP-40 lysis buffer (20 mM Tris-HCl,
150 mM NaCl, 0.5% NP-40 and 1 mM EGTA). HA-tagged
proteins were immunoprecipitated using anti-HA monoclonal
antibody (12CA5) conjugated to protein A-Sepharose. Blots were
probed in phosphate-buffered saline containing 0.1% Tween and
1% dried milk. 12CA5 (1:1000) was used to detect HA-tagged
proteins, 9E10 (1:1000) to detect Myc-tagged proteins, and
polyclonal sera against Cdc7p (1:4000) and Dbf4p (1:1000) were
used to detect those proteins.
Co-Immunoprecipitation from Sf9 Insect Cells
Sf9 cells were co-infected with HA-Cdc7p, 3Myc-ND65Polo
and Dbf4p derivatives and then immunoprecipitated as previously
described [26]. Whole cell extracts and IPs were probed with
polyclonal antibodies against Cdc7p (1:4000) and Dbf4p (1:1000)
as described above. 3Myc-ND65Polo was probed with 9E10
monoclonal antibody against Myc (1:1000).
Protein Expression, Purification, and GST-Pull Down
Cdc7p-Dbf4p kinase was purified as described [17]. GST or
GST-PBD was induced in BL21 cells for 3 hours at 37uC using
0.5 mM IPTG. Cells were sonicated in PBS containing 1% Triton
X-100 and GST proteins were purified from soluble extracts by
binding to glutathione-agarose (Amersham), elution in (20 mM
Tris-HCl, 150 mM NaCl, 1 mM EDTA and 10% glycerol)
containing 5 mM glutathione followed by dialysis against the same
buffer. 6His-tagged Sumo and Sumo-Dbf4p were expressed in
BL21 cells and extracted in HEPES extraction buffer (50 mM
HEPES-KOH, pH 7.5, 150 mM NaCl, 2 M Urea and 10%
glycerol). Proteins were loaded onto a Ni++ column and washed
(20 mM HEPES-KOH, pH 7.5, 200 mM NaCl and 10%
glycerol) before elution using an imidazole gradient. For GST
pull-downs, Sumo, Sumo-Dbf4p, GST and GST-Polo were
incubated with glutathione-agarose in the presence of buffer
(20 mM Tris-HCl pH 7.0, 300 mM NaCl, 0.5% NP-40 and
1 mM EGTA) for 1 hour at 4uC. The glutathione agarose beads
were washed extensively and bound proteins separated on 12.5%
SDS-PAGE gels. Blots were probed with polyclonal antisera raised
against GST-Polo PBD (1:1000) and yeast Smt3p (Sumo) (1:1000).
Kinase Assays
For in vitro kinase assays, purified HACdc7p-Dbf4p (100 ng)
[17] was incubated with GST or GST-Polo PBD (300 ng) at 30uC
in kinase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2,1m M
DTT, 100 mM ATP and 10 mCi of [c-
32P] ATP) for 20 minutes.
Proteins were separated on 10% SDS-PAGE and visualized by
autoradiography.
Fluorescence Microscopy
For direct fluorescence analysis of Cdc14-EGFP, cells were fixed
in 3.7% formaldehyde at room temperature for 1 hour. DNA was
stained using DAPI (1 mg/ml) for 10 minutes at room tempera-
ture. For the experiments in Figure 5A, the absence of a distinct
Cdc14-EGFP fluorescent signal (but accompanied by diffuse
nuclear and cytoplasmic fluorescence) was scored as ‘‘released.’’
Any cell that had a distinct Cdc14-EGFP nucleolar fluorescence
was counted as sequestered. Spindle morphology was detected
after spheroplasting cells and incubation in methanol/acetone
prior to incubation with antibodies: rat anti-tubulin (YOL1/34
Accurate Chemicals, 1:10) and goat anti-rat FITC (Jackson
Immunoresearch, 1:50). Cells were imaged using a 606objective.
Supporting Information
Figure S1 Western blot of Gal4-DNA binding domain fusions to
various Dbf4 N-terminal fragments for the 2-hybrid assays shown
in Figure 1.
Found at: doi:10.1371/journal.pgen.1000498.s001 (3.15 MB TIF)
Figure S2 Cdc7p-Dbf4p does not alter Polo kinase abundance
or activity. (A) WT (K6019) and dbf4-ND109 (M1874) containing
CDC5-HA3 were arrested in G1, released into the cell cycle and
blotted for Cdc5-HA3 protein. Budding index is shown. (B) DBF4
CDC5-4XGFP SPC42-eqRFP (M2750) and dbf4-ND109 CDC5-
4XGFP SPC42-eqRFP (M2748) were arrested in G1 phase with
mating pheromone and released into nocodazole. These were
scored for Cdc5-4XGFP localization to the spindle pole body. (C)
Strains expressing Cdc5-3HA protein were arrested at 30uC with
alpha-factor (a) and released into YPD containing 0.2 M
hydroxyurea (HU) or 15 mg/ml nocodazole (Noc) for 2 hours.
Extracts were blotted for Cdc5 protein and Cdc5p kinase activity
was measured following IP (D) Quantitation of kinase activity from
three independent experiments.
Found at: doi:10.1371/journal.pgen.1000498.s002 (0.75 MB TIF)
Figure S3 Deletion of the Dbf4p PIR causes decreased growth
in the presence of spindle poisons. Indicated strains were spotted at
10-fold serial dilutions on YPD or YPD containing 10 mg/ml
benomyl.
Found at: doi:10.1371/journal.pgen.1000498.s003 (2.47 MB TIF)
Figure S4 (A) Deletion of the Dbf4p PIR does not enhance
nucleolar segregation in cdc5-1 cells. DBF4, dbf4-ND109, cdc5-1
and cdc5-1 dbf4-ND109 cells transformed with a centromeric
EGFP-Nop1 plasmid were arrested in G1 with mating pheromone
and released into the cell cycle in YPD at 34uC. Alpha-factor was
added back after budding to permit a single cell cycle. Samples
were taken at the indicated time points and scored for the presence
of one or two GFP signals by florescence microscopy. (B) Deletion
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with deletion of FOB1. Dfob1 CDC14-EGFP (M3149) and Dfob1
dbf4-ND109 CDC14-EGFP (M3148) were arrested in G1 with
mating pheromone and released into the cell cycle at 30uC. Alpha-
factor was added back after budding to follow a single cell cycle.
Samples were taken at the indicated time points and scored for
release of Cdc14 from the nucleolus.
Found at: doi:10.1371/journal.pgen.1000498.s004 (0.22 MB TIF)
Figure S5 Some Dbf4p persists after Cdc20 activation during an
unperturbed cell cycle. PDS1-HA3 DBF4-Myc18 (M3161) was
arrested in G1 with mating pheromone and released into the cell
cycle at 20uC. Samples were taken at the indicated time points.
Protein extracts were made for Western blotting and cells
processed for DNA content analysis by flow cytometry. Western
blots were probed with 9E10 a-Myc (Dbf4-Myc18) and 12CA5 a-
HA (Pds1-HA) antibodies.
Found at: doi:10.1371/journal.pgen.1000498.s005 (3.24 MB TIF)
Table S1 Yeast strains used in this study.
Found at: doi:10.1371/journal.pgen.1000498.s006 (0.08 MB
DOC)
Table S2 Plasmids used in this study.
Found at: doi:10.1371/journal.pgen.1000498.s007 (0.05 MB
DOC)
Text S1 Supplementary methods: Cdc5 protein abundance,
kinase activity, and SPB localization; nucleolar segregation assay;
and Dbf4 cell cycle abundance.
Found at: doi:10.1371/journal.pgen.1000498.s008 (0.03 MB
DOC)
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